Christopher Page
Harefield Hospital
4 Papers
72 Citations
Christopher Page is an academic researcher from Harefield Hospital. The author has contributed to research in topics: Antigen & Endothelium. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Identification of antigen presenting cells in normal and transplanted human heart: importance of endothelial cells.
TL;DR: In normal heart presentation of allogeneic class II is by the intercellular adhesion molecule-1-positive endothelial cells, and after transplantation, there is an influx of recipient cells of the macrophage/dendritic series which are probably able to process allogeneIC class II.
25
Immunocytochemical markers of activation in cardiac transplant rejection
TL;DR: Capillary endothelial cells, which constitutively express Class II DR antigen and ICAM-1 in normal heart show increased of endothelial antigens Pal-E and FVIII-RA during rejection, demonstrating perturbation of the endothelial system during rejection and possibly indicate damage to the capillary endothelium.
22
Immunocytochemical changes suggestive of damage to endothelial cells during rejection of human cardiac allografts.
TL;DR: Investigation of the expression of the endothelial markers EN4, Pal-E, and FVIII-RA in normal human heart, cardiac biopsies from patients with various cardiac diseases, and heart-transplant recipients undergoing acute rejection or free of rejection suggests results do not reflect vascular damage due to cyclosporine but may well reflect damage caused by the rejection process.
19
Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro.
TL;DR: Both allogeneic and xenogeneic T cell/endothelial responses should be inhibited by therapeutic levels of CsA in vivo, assuming the absence of trans-stimulation by B7 molecules.
14